After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Biomarin Pharmaceutical Inc is $11.03B. A total of 1.38 million shares were traded on the day, compared to an average of 2.18M shares.
In the most recent transaction, Burkhart Erin sold 1,786 shares of BMRN for 59.31 per share on May 20 ’25. After the transaction, the GVP, Chief Accounting Officer now owns 14,173 company shares. In a previous transaction on May 20 ’25, Burkhart Erin bought 1,786 shares at 59.31 per share.
Among the insiders who sold shares, Hubbard Cristin disposed of 273 shares on May 02 ’25 at a per-share price of $64.92. This resulted in the EVP, Chief Commercial Officer holding 32,700 shares of BMRN after the transaction. In another insider transaction, Hubbard Cristin bought 273 shares at $64.92 per share on May 02 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BMRN has a high of $94.85 and a low of $52.93.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMRN is Buy with a score of 4.56.
